Irenic Capital Management LP Has $91.27 Million Stock Holdings in Sotera Health Company $SHC

Irenic Capital Management LP lifted its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 17.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,141,822 shares of the company’s stock after purchasing an additional 782,474 shares during the period. Sotera Health accounts for 4.4% of Irenic Capital Management LP’s holdings, making the stock its 5th biggest holding. Irenic Capital Management LP owned about 1.80% of Sotera Health worth $91,267,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. BlackRock Inc. acquired a new position in Sotera Health during the 2nd quarter worth about $428,635,000. Sculptor Capital LP acquired a new stake in shares of Sotera Health in the second quarter valued at about $426,000,000. Sachem Head Capital Management LP raised its position in shares of Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after acquiring an additional 3,735,000 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of Sotera Health by 35.3% during the first quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock worth $131,413,000 after acquiring an additional 2,390,132 shares during the last quarter. Finally, Jupiter Topco LLC acquired a new position in shares of Sotera Health in the second quarter worth approximately $149,137,000. Institutional investors own 91.03% of the company’s stock.

Analyst Upgrades and Downgrades

SHC has been the topic of several analyst reports. Barclays upped their target price on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. UBS Group set a $19.00 price target on shares of Sotera Health in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. Piper Sandler reiterated an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. Finally, Citigroup lifted their target price on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $21.50.

Sotera Health Trading Down 0.7%

NASDAQ SHC opened at $18.90 on Friday. The stock has a market capitalization of $5.39 billion, a P/E ratio of 33.16 and a beta of 1.77. The business has a 50 day simple moving average of $18.35 and a 200 day simple moving average of $16.47. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The firm had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Research analysts expect that Sotera Health Company will post 0.86 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,294,515 shares of company stock worth $23,999,528 in the last quarter. 15.36% of the stock is owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.